Mesothelioma Drugs
Mesothelioma Treatment Options: Mesothelioma Drugs
Mesothelioma, a cancer primarily linked to asbestos exposure, often requires a multifaceted approach to treatment, including the use of specific drugs to target cancer cells and alleviate symptoms. Chemotherapy remains a cornerstone of mesothelioma treatment, with drugs such as Alimta (pemetrexed), Carboplatin, Cisplatin, Gemcitabine, and Navelbine commonly prescribed. These medications work by disrupting cancer cell growth, DNA replication, or cell division, ultimately slowing tumor progression and improving patient outcomes.
Additionally, emerging therapies like Onconase, a ribonuclease enzyme, show promise in clinical trials for their ability to induce apoptosis, or programmed cell death, in cancer cells. These drugs offer hope for more targeted and effective treatments for mesothelioma.
However, it’s essential to acknowledge that while these drugs can extend survival and improve quality of life for mesothelioma patients, they may also come with side effects. Nausea, fatigue, hair loss, and lowered blood cell counts are among the common adverse effects associated with chemotherapy. Thus, treatment decisions should be made collaboratively between patients and healthcare providers, weighing the potential benefits and risks of each medication in the context of the individual’s overall health and treatment goals.
TO GET HELP – Our Nationwide Toll-Free Mesothelioma Helpline Number is 888.640.0914
Mesothelioma Drug Medications
Alimta: Manufactured by Eli Lilly, Alimta (pemetrexed) is a chemotherapy drug commonly used to treat mesothelioma. It works by inhibiting the growth of cancer cells and slowing down their spread.
Carboplatin: Manufactured by Bristol Myers Squibb, Carboplatin is a chemotherapy drug that disrupts the growth and division of cancer cells, often used in combination with other medications to treat mesothelioma.
Cisplatin: Cisplatin is a chemotherapy drug that damages the DNA of cancer cells, preventing them from growing and dividing. It’s frequently used in combination with other drugs to treat mesothelioma.
Gemcitabine: Gemcitabine is an anti-metabolite drug that interferes with the DNA replication process in cancer cells, ultimately leading to their destruction. It’s often used in combination with other medications to treat mesothelioma.
Navelbine: Navelbine is a chemotherapy drug that disrupts the microtubule structures within cancer cells, inhibiting their ability to divide and spread. It’s commonly used in the treatment of mesothelioma.
Onconase: Manufactured by Alfacell Corporation, Onconase is a ribonuclease enzyme that targets cancer cells, inducing apoptosis (cell death). It has shown promise in clinical trials for the treatment of mesothelioma.
These medications are vital in the treatment of mesothelioma, working through various mechanisms to target and inhibit cancer cell growth, ultimately improving patient outcomes and quality of life.
Experimental Mesothelioma Drugs in Developemnt
At present, several mesothelioma drugs are in various stages of experimental development, showing promise in preclinical and clinical trials. Some of these drugs include:
Tremelimumab: This immunotherapy drug targets cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), enhancing the immune system’s ability to recognize and attack cancer cells. It is currently being evaluated in clinical trials for its effectiveness against mesothelioma.
Keytruda (pembrolizumab): Keytruda is a programmed cell death protein 1 (PD-1) inhibitor that helps the immune system recognize and attack cancer cells. Clinical trials are underway to assess its efficacy in treating mesothelioma, particularly in combination with other therapies.
Nintedanib: This drug inhibits multiple signaling pathways involved in tumor growth and blood vessel formation. Clinical trials are investigating its potential as a treatment for mesothelioma, particularly in combination with chemotherapy.
Vorinostat: Vorinostat is a histone deacetylase inhibitor that affects gene expression in cancer cells, potentially slowing tumor growth. Clinical trials are exploring its use in mesothelioma treatment, particularly in combination with other drugs.
Aduro Biotech’s CRS-207: CRS-207 is a live, attenuated Listeria monocytogenes-based immunotherapy designed to stimulate an immune response against mesothelin, a protein often overexpressed in mesothelioma cells. Clinical trials are ongoing to evaluate its safety and efficacy.
These experimental drugs represent promising avenues for future mesothelioma treatment, although further research is needed to determine their effectiveness and safety in clinical settings.
Asbestos Exposure and Mesothelioma Cancer
Asbestos exposure has long been associated with mesothelioma, with manufacturers acknowledging its harmful effects since the early 1920s. The first definitive link between asbestos exposure and malignant mesothelioma was established in 1964 among workers and laborers.
Over 600,000 asbestos and mesothelioma lawsuits have been filed against manufacturers and distributors for failing to protect workers from asbestos contamination and neglecting to warn them about its health risks. The World Health Organization has reported over 92,253 mesothelioma deaths across 83 countries.
Various industries, including construction, manufacturing, and shipyards, extensively used asbestos-containing products, exposing workers to deadly asbestos dust. Mesothelioma typically progresses to stages 3 and 4 upon diagnosis due to its resemblance to other respiratory conditions, making early detection challenging. Individuals with a history of asbestos exposure should undergo annual check-ups by qualified physicians.
What is Mesothelioma Cancer?
Malignant mesothelioma is a rare form of cancer that affects the lining of the lungs, abdomen, heart, and other major organs in the body. It is characterized by the presence of malignant cancer cells in the sac lining the chest (pleura) or the abdomen (peritoneum). In the United States, approximately 3,000 new cases of malignant mesothelioma are diagnosed each year. If you are experiencing any symptoms of mesothelioma, it is important to contact a doctor immediately for evaluation and diagnosis.
Diagnosed With Mesothelioma?
If you or a family member has been diagnosed with malignant mesothelioma, you likely have many questions about living with the disease and exploring legal options against asbestos manufacturers and companies responsible for your asbestos exposure. Mesothelioma is a profoundly deadly disease. According to the American Cancer Society, the average survival time for people with mesothelioma is 4-18 months.
Call our toll-free number at 800.291.0963 right now to speak with a live mesothelioma counselor who can answer many of your questions and provide you with the peace of mind you need.
Family Member Died from Mesothelioma?
If you have a family member who has died from Mesothelioma cancer, you should immediately consult with an experienced Mesothelioma diagnosis lawyer about what compensation may be available to you from asbestos trust funds that total more than $30 billion.
We have seen many families lose their right to file a lawsuit because their Statute of Limitations had expired while they were grieving. We know it is a tough time to grieve the loss of a loved one, but please do not let your Statute of Limitations expire for filing your Mesothelioma lawsuit. In most states, the Statute of Limitations is 1-3 years.
It is VERY IMPORTANT that you file your Mesothelioma claim within your state’s Statute of Limitations.
Need a Mesothelioma Lawyer?
Call our Mesothelioma Toll Free Helpline at 888.640.0914 and get help today!
There is More Than 30 Billion Dollars Set Aside for Mesothelioma and Asbestos Victims in Asbestos Bankruptcy Trusts
Mesothelioma Claims: Mesothelioma Damages
If you’ve received a diagnosis of Mesothelioma, it’s crucial to understand that you may be eligible to seek compensation for a wide range of damages. This guide will help you navigate the complex world of Mesothelioma claims, offering insights into the various types of damages you may be entitled to recover. From Mesothelioma-specific damages to economic, medical, and even punitive damages, we’ll break down what each entails, ensuring you have the knowledge you need when considering legal action. Your journey to seeking rightful compensation starts here.
TAKING LEGAL ACTION
When confronted with the devastating impact of a mesothelioma diagnosis resulting from asbestos exposure, pursuing legal action becomes a crucial step towards securing the compensation you rightly deserve. Our team is here to assist you in initiating a mesothelioma lawsuit with an experienced mesothelioma attorney, ensuring the protection of your rights and the delivery of justice. Discover today which Asbestos Trust Funds you may be eligible for to receive compensation.
SCHEDULE A FREE CASE CONSULTATION
Scheduling a free case consultation is your first step toward seeking justice in mesothelioma cancer lawsuits. We are ready to assess your unique situation and provide the guidance you will need during this challenging time. Take this essential step toward pursuing fair compensation for your mesothelioma-related injuries.
GET HELP FROM AN EXPERIENCED INJURY ATTORNEY
When dealing with the complexities of mesothelioma cancer lawsuits, getting help from an experienced injury attorney is crucial. For more than 24 years, we have assisted workers, veterans, and families in obtaining the compensation they deserved from negligent asbestos companies. Contact us at 888.640.0914 to secure the support you will need throughout your pursuit of fair and just compensation.
24 Hour Call Back Guarantee!
Fill out our free Mesothelioma case evaluation form and an experienced mesothelioma lawyer will call you to immediately start processing your claim at no cost to you.